Home > NewsRelease > Rocky Mountain Patent Advances “Concept to Company” mission with new patents
Text Movie Graphics
Rocky Mountain Patent Advances “Concept to Company” mission with new patents
Jeffrey Schell -- Denver Patent Lawyer Jeffrey Schell -- Denver Patent Lawyer
Denver, CO
Wednesday, March 14, 2018

Denver Patent Lawyer
Video Clip: Click to Watch

Rocky Mountain Patent, a critical partner to TranS1® -- a spinal device company focused on breakthrough solutions that minimize tissue trauma – announced that it has added three new Rocky Mountain Patent-prosecuted patents to TranS1's portfolio.  These patents support TranS1's ascendance into an eight-figure revenue company from the pre-seed stage having only pending patent applications.  The patents relate to two new developments associated with presacral interbody fusion, including two new expandable cages designed to create lordosis at L5-S1, along with a new technique to perform sacroiliac (SI) fusion.   

"TranS1's patent portfolio remains one of the strongest in the medical device industry," said Jeffrey Schell, president and patent attorney of Rocky Mountain Patent. "The company's strategy remains to advance the most innovative technologies to lessen tissue trauma during spine surgery and to vigorously guard those technological innovations through domestic and international patent protection strategies advanced by Rocky Mountain Patent."

Rocky Mountain Patent wins patent allowance

Jeffrey Schell plays a key role in the patent strategies of TranS1 as a board member with the company.  With Rocky Mountain Patent leading its intellectual property protection strategies, TranS1 offers a full complement of minimally invasive surgery (MIS) solutions for spinal pathologies, including the award-winning Pylon™ posterolateral decortication and bone graft placement system, the KeyLIF™ MIS Oblique Lateral Interbody Fusion system and the AxiaLIF® presacral interbody fusion system. 

In addition to its full suite of MIS procedures and devices, TranS1 has also created and continues to develop a Rocky Mountain Patent-led patent portfolio focused on spinal health technologies. The company remains committed to becoming the most innovative in the industry by developing new technologies, applying lessons learned from its development of related approaches, and by attracting the most experienced engineers and surgeons to its team. In all, TranS1 has more than 100 issued patents and has filed more than 50 new patent applications in the last three years, all driven by Rocky Mountain Patent's efforts.

About Rocky Mountain Patent
Rocky Mountain Patent is a Denver patent law firm that helps inventors, startups, and entrepreneurs transform their concepts into companies.  The firm also works with established companies to deploy white space identification techniques to advance and protect innovative concepts.  Rocky Mountain Patent features SuperLawyers-rated attorneys and staff members that have been recognized by the Denver Post and as the “Top Young Professionals in Colorado” by ColoradoBiz Magazine.  For more information, visit www.rockymountainpatent.com.

About TranS1
Headquartered in Denver, TranS1 develops medical breakthroughs to solve spinal pathologies that minimize trauma to the tissues surrounding the spine. The company’s flagship product, AxiaLIF+, is a minimally invasive option for surgeons to accomplish spinal fusion at the L5-S1 joint. The company was named Denver’s Most Innovative Workplace by the 80/95 Awards, presented by the Denver Post. In 2017, the company won the “New Spine Technology” award from Orthopedics This Week for its Pylon™ MIS Posterolateral Decortication and Bone Graft Placement System. For more information, visit www.TranS1.com.

News Media Interview Contact
Name: Connie Bursey
Title: Media Director
Group: Rocky Mountain Patent
Dateline: Denver, CO United States
Main Phone: 888-461-4443
Cell Phone: 989-397-5692
Jump To Jeffrey Schell -- Denver Patent Lawyer Jump To Jeffrey Schell -- Denver Patent Lawyer
Contact Click to Contact
Other experts on these topics